Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Feb. 03, 2018	Jan. 28, 2017	Jan. 30, 2016
Cash flows from operating activities:
Net loss	$ (18,826)	$ (2,256)	$ (8,408)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred gain on sale-leaseback	(1,465)	(1,466)	(1,465)
Amortization of deferred debt issuance costs	270	276	279
Impairment of assets	4,095	376
Depreciation and amortization	31,073	30,245	28,359
Deferred taxes, net of valuation allowance	(2,363)	26	105
Stock compensation expense	1,636	1,256	2,195
Issuance of common stock to Board of Directors	534	482	540
Changes in operating assets and liabilities:
Accounts receivable	4,068	(2,393)	(1,102)
Inventories	14,114	7,568	(9,794)
Prepaid expenses and other current assets	(1,110)	(563)	659
Other assets	60	(247)	350
Accounts payable	2,729	574	705
Deferred rent and lease incentives	297	4,487	2,084
Accrued expenses and other liabilities	(4,153)	(3,405)	3,883
Net cash provided by operating activities	30,959	34,960	18,390
Cash flows from investing activities:
Additions to property and equipment, net	(22,565)	(29,239)	(33,447)
Net cash used for investing activities	(22,565)	(29,239)	(33,447)
Cash flows from financing activities:
Net borrowings under credit facility	3,165	1,993	23,044
Principal payments on long-term debt	(7,088)	(7,312)	(7,489)
Costs associated with debt issuances			(15)
Repurchase of common stock	(4,681)
Proceeds from the exercise of stock options			101
Net cash provided by (used for) financing activities	(8,604)	(5,319)	15,641
Net increase (decrease) in cash and cash equivalents	(210)	402	584
Cash and cash equivalents:
Beginning of period	5,572	5,170	4,586
End of period	$ 5,362	$ 5,572	$ 5,170